Construction of a New 3D Cu(II) Compound with Photocatalytic Activity and Therapeutic Effect on Ventriculitis

A new Cu(II) compound, that is {[Cu(L)(ClO4)(H2O)(CH3CN)](ClO4)}n (1, L is 4-(furan-2-yl)-2,6-bis(pyridin-2-yl)pyridine), was solvothermally synthesized and structurally characterized. It features a 0D isolated unit, and these 0D isolated units are further hydrogen-bonded into a 3D supramolecular fr...

Full description

Saved in:
Bibliographic Details
Main Authors: Xingzhao Chen, Qing Mao
Format: Article
Language:English
Published: Wiley 2022-01-01
Series:Journal of Chemistry
Online Access:http://dx.doi.org/10.1155/2022/1006203
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850172069042454528
author Xingzhao Chen
Qing Mao
author_facet Xingzhao Chen
Qing Mao
author_sort Xingzhao Chen
collection DOAJ
description A new Cu(II) compound, that is {[Cu(L)(ClO4)(H2O)(CH3CN)](ClO4)}n (1, L is 4-(furan-2-yl)-2,6-bis(pyridin-2-yl)pyridine), was solvothermally synthesized and structurally characterized. It features a 0D isolated unit, and these 0D isolated units are further hydrogen-bonded into a 3D supramolecular framework. The framework of 1 can be stable up to 284°C, and the optical band gap of 1 is 3.71 eV. Under the irradiation of ultraviolet light, complex 1 as a photocatalyst exhibits high activity for methylene blue (MB) degradation in the water solution. The above compound’s inhibitory activity on the inflammatory cytokines releasing was tested through exploiting ELISA detection. The real time RT-PCR was conducted to assess the compound’s suppression on the expression of bacterial survival gene.
format Article
id doaj-art-cf4ef4656f214ad7beee6ef863f4e0fa
institution OA Journals
issn 2090-9071
language English
publishDate 2022-01-01
publisher Wiley
record_format Article
series Journal of Chemistry
spelling doaj-art-cf4ef4656f214ad7beee6ef863f4e0fa2025-08-20T02:20:09ZengWileyJournal of Chemistry2090-90712022-01-01202210.1155/2022/1006203Construction of a New 3D Cu(II) Compound with Photocatalytic Activity and Therapeutic Effect on VentriculitisXingzhao Chen0Qing Mao1Brain Injury CenterBrain Injury CenterA new Cu(II) compound, that is {[Cu(L)(ClO4)(H2O)(CH3CN)](ClO4)}n (1, L is 4-(furan-2-yl)-2,6-bis(pyridin-2-yl)pyridine), was solvothermally synthesized and structurally characterized. It features a 0D isolated unit, and these 0D isolated units are further hydrogen-bonded into a 3D supramolecular framework. The framework of 1 can be stable up to 284°C, and the optical band gap of 1 is 3.71 eV. Under the irradiation of ultraviolet light, complex 1 as a photocatalyst exhibits high activity for methylene blue (MB) degradation in the water solution. The above compound’s inhibitory activity on the inflammatory cytokines releasing was tested through exploiting ELISA detection. The real time RT-PCR was conducted to assess the compound’s suppression on the expression of bacterial survival gene.http://dx.doi.org/10.1155/2022/1006203
spellingShingle Xingzhao Chen
Qing Mao
Construction of a New 3D Cu(II) Compound with Photocatalytic Activity and Therapeutic Effect on Ventriculitis
Journal of Chemistry
title Construction of a New 3D Cu(II) Compound with Photocatalytic Activity and Therapeutic Effect on Ventriculitis
title_full Construction of a New 3D Cu(II) Compound with Photocatalytic Activity and Therapeutic Effect on Ventriculitis
title_fullStr Construction of a New 3D Cu(II) Compound with Photocatalytic Activity and Therapeutic Effect on Ventriculitis
title_full_unstemmed Construction of a New 3D Cu(II) Compound with Photocatalytic Activity and Therapeutic Effect on Ventriculitis
title_short Construction of a New 3D Cu(II) Compound with Photocatalytic Activity and Therapeutic Effect on Ventriculitis
title_sort construction of a new 3d cu ii compound with photocatalytic activity and therapeutic effect on ventriculitis
url http://dx.doi.org/10.1155/2022/1006203
work_keys_str_mv AT xingzhaochen constructionofanew3dcuiicompoundwithphotocatalyticactivityandtherapeuticeffectonventriculitis
AT qingmao constructionofanew3dcuiicompoundwithphotocatalyticactivityandtherapeuticeffectonventriculitis